TGFβ-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4

Biological Chemistry

Volumn 386, Issue 3, 2005, Pages 225-236

  Imamichi, Yukiko ^a   Waidmann, Oliver ^a   Hein, Ramona ^a   Eleftheriou, Pinelopi ^a   Giehl, Klaudia ^a   Menke, Andre ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Epithelial dedifferentiation; Extracellular signal regulated kinase (ERK); Focal complex formation; Rho GTPases; Signal transduction; Transforming growth factor (TGF )

Indexed keywords

ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 16844382294     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2005.028     Document Type: Article

References (48)

1. Ahmed, N., Niu, J., Dorahy, D.J., Gu, X., Andrews, S., Meldrum, C.J., Scott, R.J., Baker, M.S., Macreadie, I.G., and Agrez, M.V. (2002). Direct integrin αvβ6-ERK binding: implications for tumour growth. Oncogene 21, 1370-1380.
2. 2-terminal kinase. J. Cell. Biol. 149, 741-754.
3. Aplin, A.E., Howe, A., Alahari, S.K., and Juliano, R.L. (1998). Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50, 197-263.
4. Atfi, A., Djelloul, S., Chastre, E., Davis, R., and Gespach, C. (1997). Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem. 272, 1429-1432.
5. Bakin, A.V., Rinehart, C., Tomlinson, A.K., and Arteaga, C.L. (2002). p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115, 3193-3206.
6. Bhowmick, N.A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C.A., Engel, M.E., Arteaga, C.L., and Moses, H.L. (2001). Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27-36.
7. Brunton, V.G., Fincham, V.J., McLean, G.W., Winder, S.J., Paraskeva, C., Marshall, J.F., and Frame, M.C. (2001). The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cells. Neoplasia 3, 215-226.
8. Choy, L. and Derynck, R. (1998). The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response. J. Biol. Chem. 273, 31455-31462.
9. Derynck, R. and Feng, X.H. (1997). TGF-β receptor signaling. Biochim. Biophys. Acta 1333, F105-150.
10. Derynck, R. and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425, 577-584.
11. Ebner, R., Chen, R.H., Lawler, S., Zioncheck, T., and Derynck, R. (1993). Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science 262, 900-902.
12. Edlund, S., Landström, M., Heldin, C.H., and Aspenström, P. (2002). Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 13, 902-914.
13. Ellenrieder, V., Hendler, S.F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G., and Gress, T.M. (2001). Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61, 4222-4228.
14. Engel, M.E., McDonnell, M.A., Law, B.K., and Moses, H.L. (1999). Interdependent Smad and JNK signaling in transforming growth factor-β-mediated transcription. J. Biol. Chem. 274, 37413-37420.
15. Etienne-Manneville, S. and Hall, A. (2002). Rho GTPases in cell biology. Nature 420, 629-635.
16. Fincham, V.J., James, M., Frame, M.C., and Winder, S.J. (2000). Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 19, 2911-2923.
17. Giehl, K., Seidel, B., Gierschik, P., Adler, G., and Menke, A. (2000). TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene 19, 4531-4541.
18. Griswold-Prenner, I., Kamibayashi, C., Maruoka, E.M., Mumby, M.C., and Derynck, R. (1998). Physical and functional interactions between type I transforming growth factor β receptors and Bα, a WD-40 repeat subunit of phosphatase 2A. Mol. Cell. Biol. 18, 6595-6604.
19. Hocevar, B.A., Brown, T.L., and Howe, P.H. (1999). TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345-1356.
20. Huang, C., Rajfur, Z., Borchers, C., Schaller, M.D., and Jacobson, K. (2003). JNK phosphorylates paxillin and regulates cell migration. Nature 424, 219-223.
21. Huang, C., Jacobson, K., Schaller, M.D. (2004). MAP kinases and cell migration. J. Cell Sci. 117, 4619-4628.
22. Inman, G.J., Nicolas, F.J., Callahan, J.F., Harling, J.D., Gaster, L.M., Reith, A.D., Laping, N.J., and Hill, C.S. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
23. Jaffe, A.B. and Hall, A. (2002). Rho GTPases in transformation and metastasis. Adv. Cancer Res. 84, 57-80.
24. Klemke, R.L., Cai, S., Giannini, A.L., Gallagher, P.J., Lanerolle, P.D., and Cheresh, D.A. (1997). Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481-492.
25. Massague, J., Blain, S.W., and Lo, R.S. (2000). TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103 295-309.
26. Menke, A., Philippi, C., Vogelmann, R., Seidel, B., Lutz, M.P., Adler, G., and Wedlich, D. (2001). Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res. 61, 3508-3517.
27. Miettinen, P.J., Ebner, R., Lopez, A.R., and Derynck, R. (1994). TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021-2036.
28. Mulder, K.M. (2000). Role of Ras and MAPKs in TGFβ signaling. Cytokine Growth Factor Rev. 11, 23-35.
29. Nobes, C.D. and Hall, A. (1999). Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235-1244.
30. Pouliot, F. and Labrie, C. (1999). Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. Int. J. Cancer 81, 98-103.
31. Ren, X.D. and Schwartz, M.A. (2000). Determination of GTP loading on Rho. Methods Enzymol. 325, 264-272.
32. Ridley, A.J. (2001). Rho GTPases and cell migration. J. Cell Sci. 114, 2713-2722.
33. Roberts, A.B. and Wakefield, L.M. (2003). The two faces of transforming growth factor β in carcinogenesis. Proc. Natl. Acad. Sci. USA 100, 8621-8623.
34. Roberts, A.B., Flanders, K.C., Heine, U.I., Jakowlew, S., Kondaiah, P., Kim, S.J., and Sporn, M.B. (1990). Transforming growth factor-β: multifunctional regulator of differentiation and development. Phil. Trans. R. Soc. Lond. B Biol. Sci. 327, 145-154.
35. Rout, U.K., Saed, G.M., and Diamond, M.P. (2002). Transforming growth factor β1 modulates expression of adhesion and cytoskeletal proteins in human peritoneal fibroblasts. Fertil. Steril. 78, 154-161.
36. Salvesen, G.S. and Duckett, C.S. (2002). IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410.
37. Sander, E.E., van Delft, S., ten Klooster, J.P., Reid, T., van der Kammen, R.A., Michiels, F., and Collard, J.G. (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143, 1385-1398.
38. Shen, X., Li, J., Hu, P.P., Waddell, D., Zhang, J., and Wang, X.F. (2001). The activity of guanine exchange factor NET1 is essential for transforming growth factor-β-mediated stress fiber formation. J. Biol. Chem. 276, 15362-15368.
39. Stähle, M., Veit, C., Bachfischer, U., Schierling, K., Skripczynski, B., Hall, A., Gierschik, P., and Giehl, K. (2003). Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J. Cell Sci. 116, 3835-3846.
40. Stupack, D.G., Cho, S.Y., and Klemke, R.L. (2000). Molecular signaling mechanisms of cell migration and invasion. Immunol. Res 21 83-88.
41. Subauste, M.C., Pertz, O., Adamson, E.D., Turner, C.E., Junger, S., and Hahn, K.M. (2004). Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165, 371-381.
42. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C.H. (1994). Characterization of type I receptors for transforming growth factor-β and activin. Science 264 101-104.
43. Ventura, F., Liu, F., Doody, J., and Massague, J. (1996). Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-a in yeast and mammalian cells. J. Biol. Chem. 271, 13931-13934.
44. Wakefield, L.M. and Roberts, A.B. (2002). TGFβ signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
45. Webb, D.J., Donais, K., Whitmore, L.A., Thomas, S.M., Turner, C.E., Parsons, J.T., and Horwitz, A.F. (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154-161.
46. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F., and Massague, J. (1992). TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
47. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T.K., Andries, M., Smith, J.C., Heldin, C.H., and Miyazono, K. (1995). Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130, 217-226.
48. Yue, J. and Mulder, K.M. (2000). Activation of the mitogen-activated protein kinase pathway by transforming growth factor β. Methods Mol. Biol. 142, 125-131.